Antagonistic analogs of GH-RH inhibiting IGF-I and -II

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S324000, C530S317000

Reexamination Certificate

active

07026281

ABSTRACT:
There is provided a novel series of synthetic analogs of hGH-RH(1–29)NH2. These analogs inhibit the activity of endogenous hGH-RH, and therefore prevent the release of growth hormone. The stronger inhibitory potencies of the new analogs, as compared to previously described ones, results from replacement of various amino acids.

REFERENCES:
patent: WO-95/16707 (1995-06-01), None
Wang, J. et al. 2000 J. Biol. Chem. 275 (1): 507-513.
Section 3.4 Counting, Permutations, and Combinations for counting rules.
Seto et (1990, Biochem. Biophys. Res. Commun 167, 360-336).
Bowie et al (Science, 1990, 247:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Hartwell et al (Science, 1997, 278:1064-1068).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antagonistic analogs of GH-RH inhibiting IGF-I and -II does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonistic analogs of GH-RH inhibiting IGF-I and -II, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonistic analogs of GH-RH inhibiting IGF-I and -II will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3564407

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.